Giovanni Di Pasquale

Title: Giovanni Di Pasquale: Innovator in Gene Therapy

Introduction

Giovanni Di Pasquale is a prominent inventor based in Kensington, MD (US). He has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated viral (AAV) vectors for medical treatments. With a total of 4 patents, his work focuses on innovative methods to address various health conditions.

Latest Patents

Di Pasquale's latest patents include groundbreaking inventions such as an AAV vector with a unique capsid protein VP1. This invention provides a novel AAV vector that comprises a capsid with specific amino acid sequences, which can encode therapeutic proteins for treating conditions like methylmalonic acidaemia (MMA). Another notable patent involves AAV-mediated gene transfer to salivary glands, aimed at protecting subjects from diabetes or obesity. This method utilizes an AAV vector that encodes an exendin-4 protein, showcasing Di Pasquale's commitment to advancing gene therapy techniques.

Career Highlights

Throughout his career, Giovanni Di Pasquale has been associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in developing innovative solutions for complex health issues, particularly through the use of AAV vectors.

Collaborations

Di Pasquale has collaborated with notable professionals in his field, including John A Chiorini and Michael Schmidt. These partnerships have further enhanced his research and development efforts, contributing to the advancement of gene therapy.

Conclusion

Giovanni Di Pasquale stands out as a key figure in the field of gene therapy, with a focus on innovative AAV vector technologies. His contributions are paving the way for new treatment methods that could significantly impact patient care.